Induction of selective cytotoxicity and apoptosis in human T4-lymphoblastoid cell line (CEMss) by boesenbergin a isolated from boesenbergia rotunda rhizomes involves mitochondrial pathway, activation of caspase 3 and G2/M phase cell cycle arrest by Kuan-Beng Ng et al.
Ng et al. BMC Complementary and Alternative Medicine 2013, 13:41
http://www.biomedcentral.com/1472-6882/13/41RESEARCH ARTICLE Open AccessInduction of selective cytotoxicity and apoptosis
in human T4-lymphoblastoid cell line (CEMss) by
boesenbergin a isolated from boesenbergia
rotunda rhizomes involves mitochondrial
pathway, activation of caspase 3 and G2/M phase
cell cycle arrest
Kuan-Beng Ng1, Ahmad Bustamam1*, Mohd Aspollah Sukari2, Siddig Ibrahim Abdelwahab3, Syam Mohan4,
Michael James Christopher Buckle4, Behnam Kamalidehghan4, Nabilah Muhammad Nadzri1, Theebaa Anasamy1,
A Hamid A Hadi5 and Heshu Sulaiman Rahman6Abstract
Background: Boesenbergia rotunda (Roxb.) Schlecht (family zingiberaceae) is a rhizomatous herb that is distributed
from north-eastern India to south-east Asia, especially in Indonesia, Thailand and Malaysia. Previous research has
shown that the crude extract of this plant has cytotoxic properties. The current study examines the cytotoxic
properties of boesenbergin A isolated from Boesenbergia rotunda.
Methods: MTT assay was used to check the cytotoxicity of boesenbergin A. The morphological assessment of
apoptosis was monitored using normal and fluorescence microscopy. The early and late phase of apoptosis was
investigated using annexin V and DNA laddering assays, respectively. The mitochondrial membrane potential (MMP)
was assessed by fluorescence microscopy. Human apoptosis proteome profiler assays were performed to
investigate the mechanism of cell death. In addition, the protein levels of Bax, Bcl2 and HSP 70 were also analyzed
using western blot. Assays of caspase =-3/7, -8 and =-9 were carried out in order to test for induction during
treatment. Lastly, cell cycle progression was analyzed using flow cytometry.
Results: Boesenbergin A was found to have the highest toxicity towards CEMss cancer cells (IC50 = 8 μg/ml). The
morphology of CEMss cells after treatment showed evidence of apoptosis that included blebbing and chromatin
condensation. The annexin V assay revealed that early apoptosis is induced after treatment. The DNA laddering
assay confirmed that DNA fragmentation had occurred during late apoptosis. The cell cycle analysis indicated that
boesenbergin A was able to induce G2/M phase arrest in CEMss cells. The activity of caspases -3/7, -8 and -9 was
increased after treatment which indicates both intrinsic and extrinsic pathways are induced during apoptosis. The
involvement of mitochondria was established by increased mitochondrial membrane potential and up and down
regulation of Bcl2 and Bax proteins as well as HSP70.
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Conclusion: In conclusion, the results demonstrated that boesenbergin A induced apoptosis of CEMss cells
through Bcl2/Bax signaling pathways with the involvement of caspases and G2/M phase cell cycle arrest. The
current findings warrant further research on boesenbergin A as a novel chemotherapeutic agent for leukemia
intervention including studies in animal models.
Keywords: Boesenbergia rotunda, Boesenbergin A, CEMss, Anticancer, CytotoxicityFigure 1 (A) Structure of Boesenbergin A and (B) Cytotoxicity
of BA in different cell lines.Background
Leukemia is a cancer of blood-forming organs, such as
bone marrow, which is characterized by the uncontrolled
proliferation of abnormal blood cells [1]. In a national
childhood cancer survey carried out in Malaysia, it was
found that leukemia is the commonest childhood tumor.
The crude incidence rate of pediatric malignancies in
Malaysia was 77.4 per million children aged less than
15 years with leukemia as the fourth leading cause of
cancer related death in 1998 [2].
There are about 20,000 species of tropical plants, of
which about 1,300 are said to be medicinal and potential
sources for screening of anticancer agents [3]. Some of the
plant extracts from these medicinal plants are reported to
have potential to be developed as drugs [4]. Boesenbergia
rotunda (L.) (Fingerroot), formerly known as Boesenbergia
or Kaempferia pandurata (Roxb). Schltr. (Zingiberaceae),
is distributed in south-east Asian countries, such as
Indonesia, Malaysia and Thailand. The rhizomes of
this plant have been used for the treatment of peptic
ulcer, as well as colic, oral diseases, urinary disorders,
dysentery and inflammation [5]. Several studies have
suggested this plant to be neuroprotective and to show
anti-inflammatory, anti-mutagenic, anticancer, chemopre-
ventive, anti-dermatophytic, anti-Helicobacter pylori and
anti-dengue-2 virus NS3 protease activity [6]. This plant
possesses both anti-oxidant, as well as anticancer properties
which can help to cure cancer.
Among the compounds that have been isolated from
Boesenbergia rotunda are flavonoids, pinocembrin and
alpinetin, and chalcones, panduratin A, cardamonin and
boesenbergin A [7,8]. There are varieties of important
biological compounds central core are formed by aromatic
ketones from chalcones. The central core contains two aro-
matic rings with an unsaturated chain and it shows antibac-
terial, antifungal, chemopreventive, antiviral, antiprotozoal,
insecticidal, anticancer, and anti-inflammatory properties
[9-11]. One of the chalcones that are already being studied
by quite a number of scientists is panduratin A. Of these
panduratin A has been shown to be capable of inducing
apoptosis and cell cycle arrest in human prostate cancer
cells PC3 and DU145 [12] and of inhibiting the growth
of A549 cells through induction of apoptosis andinhibition of NF-kB translocation [13]. On the other
hand, only preliminary studies of the cytotoxic activity
of boesenbergin A against HL-60 cells have been
reported [14]. Following on from recent findings in our
research group that boesenbergin A also has cytotoxic
activity against A549, PC3, HepG2, HT-29, and WRL-68
cells [15], the present study boesenbergin A (Figure 1)
explores its anticancer potential in human acute lympho-
blastic leukemia cells (CEMss) in vitro.
Methods
Plant materials
The rhizomes of B. rotunda were purchased from Puchong
Market, Selangor Darul Ehsan, Malaysia. The material
was identified by a botanist at the Faculty of Science,
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was deposited (BR-R11-01). The isolation and identifi-
cation of boesenbergin A has been previously reported
by us in detail [14].
Cell culture conditions
Estrogen receptor positive cells (MCF-7) and cervical can-
cer cells (Hela) were obtained from ATCC (USA). Human
T4-lymphoblastoid cell line CEMss were obtained from
NIH AIDS Research and Reference Reagent Program (Div-
ision of AIDS, NIAID, NIH: USA). The cell lines were
grown at 37°C in a humidified CO2 incubator with 5%
CO2 in RPMI-1640 (Sigma, MO, USA) supplemented with
10% fetal bovine serum (Invitrogen Corp., Auckland, N.Z.).
Cytotoxicity assay
Adherent cells (1× 106 cells/ml) were grown in 96-well
plates overnight, whereas CEMss cells (1× 106 cells/ml) were
plated directly into 96-well plates on the drug treatment
day. Boesenbergin A was dissolved in dimethylsulfoxide
(DMSO) and media. The final concentration of DMSO was
0.1% (v/v). Different concentrations of the sample were
prepared with serial dilution. Dimethylsulfoxide (0.1%) was
used as a control. The toxicity profiles of the compound
were assessed using the 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT) microculture tetrazo-
lium viability assay as described previously [16]. Thereafter,
various concentrations of compound (with a maximum of
100 μg/ml) were plated out in triplicate. Each plate included
untreated cell controls and a blank cell-free control. After
72 h of incubation, MTT (5 mg/ml) was added to each
well and the plates incubated for a further 4 h before re-
moval of the media. DMSO was then added into each
well to solubilize the formazan crystals. The absorbance
was read at wavelength of 595 nm using a microtitre
plate reader (Labsystems iEMS Reader MF). The per-
centage cellular viability was calculated with the appro-
priate controls taken into account. The concentration
which inhibited 50% of cellular growth (IC50 value) was
determined. All experiments were carried out in tripli-
cate (Figure 1B).
The inhibitory rate of cell proliferation was calculated by
the following formula: Growth inhibition = (OD control –
OD treated) / OD control X 100. The cytotoxicity of
sample on cancer cells was expressed as IC50 values (the
drug concentration reducing the absorbance of treated
cells by 50% with respect to untreated cells). The
determined IC50 value was used for many of the subse-
quent experiments.
Cytotoxicity of boesenbergin A on proliferated primary
human blood lymphocytes
The ability of boesenbergin A to act selectively on can-
cer cells especially leukemia was evaluated by comparingthe cytotoxicity of this compound towards primary
human blood lymphocytes. Briefly, blood was collected
into a cell preparation tube containing sodium citrate
(BD VacutainerW, New Jersey, USA). After collection,
tube was stood upright for 20 min at room temperature
to allow it to equilibrate and was then centrifuged at
1200xg for 20 min. Mononuclear cells and platelets
underneath the plasma layer were collected using a pipette
and transferred into a 15 ml centrifuge tube. The cells were
washed twice with PBS and cultured in complete Quantum
PBL media with phytohemagglutinin (PAA, Pasching,
Austria) containing 10% FBS supplemented with 100 U/ml
penicillin and 100 μg/ml streptomycin at 37°C in 5% CO2
atmosphere. Primary human blood lymphocytes (1 × 106
cells/ml) were treated at various concentrations of
boesenbergin A in triplicate and cell viability was measured
using MTT assay after 48 h of incubation. The cell lines
used as normal cells were human peripheral blood
lymphocytes obtained from normal healthy donors after
informed consent was given. This project was approved
by the medical research ethics committee (founded in
2002) of the medical Faculty of UPM at a meeting on
April 12, 2012 (UPM 2564/004/12).
Microscopic observation of cellular morphology using
phase contrast inverted microscope
This analysis examined whether apoptosis may be
implicated in mediating cell death amongst CEMss cells
elicited by boesenbergin A. CEMss cells at a concentra-
tion of 1 × 106 cells/ml were cultured in RPMI 1640
(PAA, Cölbe, Germany) medium containing 10% FBS
was seeded into a 25 ml culture flask (TPP, Trasadingen,
Switzerland) and treated with boesenbergin A (8 μg/ml)
at different time periods (24, 48 and 72 h). The morpho-
logical appearance of treated cells was compared with
the untreated control by using a normal inverted micro-
scope post-treatment [17]. CEMss cells were treated
with the compound for 24, 48 and 72 h. Untreated cells
served as the negative control.
Quantification of apoptosis using propidium iodide and
acridine orange double staining
Boesenbergin A-induced cell death in CEMss cells was
quantified using propidium iodide (PI) and acridine orange
(AO) double staining according to standard procedures
and examined under a fluorescence microscope (Lieca
attached with Q-Floro Software). Briefly, treatment was
carried out in a 25 ml culture flask (Nunc). CEMss cells
were plated at a concentration of 1 × 106 cells/ml and
treated with boesenbergin A (8 μg/ml). The cells were
incubated in 5% CO2 atmosphere at 37°C for 24, 48 and
72 h and then spun down at 200 g for 10 min. The super-
natant was discarded and the cells were washed twice using
PBS after centrifuging at 200 g for 10 min to remove the
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containing AO (10 μg/ml) and PI (10 μg/ml) were added
into the cellular pellet at equal volumes of each. The
freshly stained cell suspension was dropped into a glass
slide and covered by cover slip. Slides were observed
under a UV-fluorescence microscope within 30 min
before the fluorescence colour started to fade. The
percentages of viable, early apoptotic, late apoptotic and
secondary necrotic cells were determined in more than
200 cells. Acridine orange (AO) and propidium iodide (PI)
are intercalating nucleic acid specific fluorochromes which
emit green and orange fluorescences respectively, when
they are bound to DNA. Of the two, only AO can cross
the plasma membrane of viable and early apoptotic cells.
The criteria for identification are as follows: (a) viable cells
appear to have a green nucleus with an intact structure;
(b) early apoptotic cells exhibit a bright-green nucleus
showing condensation of chromatin in the nucleus; (c) late
apoptotic cells show dense orange areas of chromatin con-
densation; (d) secondary necrotic cells appear to have an
orange intact nucleus [18]. This assay provides a useful
quantitative evaluation and was carried out in triplicate.
Flow cytometric analysis of DNA cell cycle
CEMss cells at concentration of 1 × 106 cells/ml were
cultured in RPMI 1640 (PAA) medium containing 10%
FBS seeded in to 25 ml culture flask (TPP) and treated
with boesenbergin A (8 μg/ml) at different time periods
(24, 48 and 72 h). After incubation, the cells were spun
down by centrifugation at 200 g for 10 min. The super-
natant was discarded and the pellet was washed with
PBS twice to remove any remaining media. To restore
the integrity, fixation of the cell population for flow
cytometery analysis was performed. Briefly, cell pellets
were fixed by mixing 500 μl of 70% cold ethanol and
250 μl of cell suspension and kept at −20°C overnight.
The cells were then spun down at 200 g for 10 min and
the ethanol was decanted. After washing twice with PBS,
the cells were resuspended in PBS. Twenty microliters
of RNase A (10 μg/ml) and 2 μl of PI (2.5 μg/ml) were
added and the fixed cells were kept in the dark on ice
for 30 min. Propidium iodide has the ability to bind to
RNA molecules and hence RNase enzyme was added in
order to allow PI to bind directly to DNA. The DNA
content of cells was then analyzed using a flow cytometer
(BD FACSCanto™ II). The fluorescence intensity of the
subG1 cell fraction represents the apoptotic cell population.
Annexin V assay
CEMss cells (1 × 106 cells/ml) were exposed to boesenbergin
A (8 μg/ml) for 24, 48 and 72 h and the annexin V assay
performed using an annexin V:FITC assay kit (ABD
Serotec, UK). Briefly the treated cells were centrifuged for
10 min at 200 g to remove the media. After that, PBS wasadded to wash the cells and the same process was repeated
twice. Then 5 μl annexin V:FITC was added to 195 μl of
the cell suspension binding buffer, which was prepared by
diluting the binding buffer 1:4 in distilled water (50 ml
binding buffer +150 ml distilled water). The suspension
was then mixed and incubated for 10 min in the dark at
room temperature. The cells were then washed and
resuspended in 190 μl prediluted binding buffer. Then
10 μl of the PI solution was added to the cell suspension
and the sample was analyzed using a flow cytometer (BD
FACSCanto™ II).DNA laddering
The Apoptotic DNA Ladder Detection kit (CHEMICON
International Inc., CA, USA) was used for DNA extraction
from cells. Briefly, CEMss cells treated with boesenbergin
A (16 μg/ml) were collected at 24 and 48 h post treatment.
The cells were washed with PBS and the cells were spun
down by centrifugation at 500 × g for 5 min. After removal
of the supernatant, the cells were lysed by the addition of
40 μl of TE lysis buffer and gentle pipetting, followed by
the addition of 5 μl of Enzyme A (RNase A) into the crude
lysate and incubated at 37°C for 10 min. Then 5 μl of
Enzyme B (Proteinase K) was added and the lysate was
further incubated at 50°C for 30 min. Then 5 μl of am-
monium acetate solution and 50 μl of isopropanol were
added and mixed well and the suspension was kept at
−20°C for 10 min. The sample was then centrifuged
16000 × g for 10 min at to precipitate the DNA. After
washing the DNA pellet with 70% ice cold ethanol, the
air dried pellet was dissolved in 30 μl of DNA suspen-
sion buffer. For detecting the DNA ladder, the extracted
DNA samples were run on 1% agarose gel in tris–acetic
acid–EDTA buffer. After electrophoresis, the gel was
stained with ethidium bromide (Gibco BRL, Paisley,
Scotland), visualized with a UV light transilluminator
(UVP, Upland, CA, USA) and photographed.Caspase-3/7, -8 and -9 activity assay
Assays of caspase-3/7, -8 and =-9 was performed using
the Caspase-Glo Assay kit (Promega, WI, USA). CEMss
cells were plated and treated with boesenbergin A
(8 μg/ml) and incubated for 24, 48 and 72 h in 96 well
white plates. After allowing the cells to equilibriate at
room temperature, 50 μl of Caspase-GloW reagent was
added to each well containing 50 μl of blank, negative
control cells and treated cells in culture medium. The
contents of the plate were gently mixed using a plate shaker
at 100 g for 30 sec. It was then incubated at room
temperature for 30 min in the dark. Readings were taken
every 10 min for 3 h using a luminescence microplate
reader (Infinite M200PRO, Tecan, Männedorf, Switzerland).
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Rhodamine 123 (Rh123) is a fluorescent cationic dye
that binds to polarized mitochondrial membrane and
accumulates as aggregates in the mitochondria of nor-
mal cells. Rh123 was prepared in ethanol as a 5 mg/ml
stock solution. CEMss cells were treated with 8 μg/ml
boesenbergin A for 24, 48 and 72 h. At the end of the
reaction time, the cells were harvested and washed twice
in cold PBS, then resuspended in Rh123 (2 μg/ml) for
30 min in the dark. The Rh123 staining intensity was
captured using a fluorescence microscope. Intensity of
Rh 123 is directly related to mitochondrial membrane
potential. The percentage of rhodamine negative cells
gives the percentage collapse of Mitochondria Mem-
brane Permeability.Human apoptosis proteome profiler array
To investigate the pathways by which boesenbergin A
induces apoptosis, we performed a determination of
apoptosis-related proteins using the Proteome Profiler
Array (RayBioW Human Apoptosis Antibody Array Kit,
RayBiotech, GA, USA), according to the manufac-
turer’s instructions. Briefly, the cells where treated with
boesenbergin A. Three hundred micrograms of protein
from each sample were incubated with the human apop-
tosis array overnight. The apoptosis array data was quanti-
fied by scanning the membrane on a Biospectrum AC
ChemiHR 40 (UVP, Upland, CA, USA) and analysis of the
array image file was performed using image analysis soft-
ware according to the manufacturer’s instructions.Table 1 Effect of boesenbergin A on the viability of MCF-7,
Hela and CEMss cells for 72 h
Cell type IC 50 ± SD (μg /ml)
MCF-7 25.43 ± 0.36
Hela 12.21 ± 0.28
CEMss 8.11 ± 0.44
Each value represents means ± SD.Western blot analysis
CEMss cells were seeded in 12-well plates and treated
with boesenbergin A (8 μg/ml) at 3, 6, 12 and 24 h. The
total protein of the cells was extracted with cell lysis
buffer (50 mM Tris–HCl pH 8.0, 120 mM NaCl, 0.5%
NP-40, 1 mM PMSF). Forty micrograms of protein ex-
tract was separated by 10% SDS-PAGE, transferred to a
polyvinylidenedifluoride (PVDF) membrane (Bio-Rad),
blocked with 5% nonfat milk in TBS-Tween buffer 7
(0.12 M Tris-base, 1.5 M NaCl, 0.1% Tween20) for 1 h
at room temperature, incubated with the appropriate
antibody overnight at 4°C and then incubated with
horseradish peroxidase conjugated secondary antibody
for 30 min at room temperature. The bound antibody
was detected with peroxidase-conjugated anti-rabbit
antibody (1:10000) or anti-mouse antibody (1:10000)
followed by chemiluminescence (ECL System) and exposed
by autoradiography. The following primary antibodies
β-actin (1:10000), Bcl2 (1:1000), Bax (1:1000), HSP70
(1:1000), were purchased from Santa Cruz Biotechnol-
ogy, Inc, (California, USA).Statistical analysis
Data is reported as the mean ± SD of three replicates. The
independent t-test and ANOVA were used for comparisons
with P < 0.05 considered to be significant. All statistical
analyses were performed using the SPSS software (Release
18, SPSS Inc, Chicago, IL, USA).Results
Cell growth cytotoxic assay
Several human cancer cell lines were used to screen the
cytotoxicity of the boesenbergin A. The IC50 value on
the viability of CEMss cells was determined to be 8.11 ±
0.44 μg/ml (20.07 μM). In addition, boesenbergin A also
showed toxicity towards MCF-7 and Hela cells at IC50
values of 25.43 ± 0.36 μg/ml (62.95 μM) and 12.21 ±
0.28 μg/ml (30.22 μM), respectively (Table 1). The posi-
tive control used, 5-fluouracil produced an inhibitory
effect on CEMss cells with an IC50 value of 1.43 ±
0.06 μg/ml. The results revealed that boesenbergin A
demonstrated the highest toxicity towards CEMss cells.
Hence CEMss cells were selected and used to further
analyse the cytotoxic potential of boesenbergin A.Cytotoxicity of boesenbergin A on proliferated primary
human blood lymphocytes
From experiments carried out for 48 h, it was found that
boesenbergin A has no toxic effect against primary human
blood lymphocytes (Table 2).Microscopic observation of cellular morphology using
phase contrast inverted microscope
The study revealed that treatment of CEMss cells with
boesenbergin A triggered morphological changes, which
indicates that apoptosis occurred in a time-dependent
manner. Figure 2 shows several morphological changes
of treated and untreated CEMss cells at 24, 48 and 72 h
post-treatment under 400 X magnification. Treated
CEMss cells showed obvious changes indicating induc-
tion of apoptosis as compared to untreated cells. These
features included blebbing of the cell membrane, prom-
inent growth inhibition such as chromatin condensation
and cell shrinkage. On the contrary, untreated cells
remained confluent throughout the incubation period.
Table 2 Effect of boesenbergin A on proliferated primary human blood lymphocyte for 48 h
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acridine orange double staining
In order to quantify the degree of apoptosis, propidium
iodide (PI) and acridine orange (AO) double-staining was
used in this experiment. CEMss cells were scored under a
confocal microscope after treatment, in order to quantify
the number of cells that are categorized as viable, early
apoptotic, late apoptotic and secondary necrotic. A total
of 200 cells were used arbitrarily and differentially, to-
gether with an untreated negative control for scoring. TheFigure 2 Microscopic observation of cellular morphology using phase
IC50 Boesenbergin A in time-dependent manner. (A) Untreated cells showe
necrosis. (B) Early apoptosis features were seen after 24 h representing (arrow
blebbing with chromatin condensation was seen during late apoptosis after 7study revealed that boesenbergin A triggered morpho-
logical changes in treated CEMss cells that indicated
possible induction of apoptosis upon treatment in a
time dependent manner. The presence of intercalated
AO within fragmented DNA indicates early apoptosis.
At 24 h after treatment with boesenbergin A, blebbing
and nuclear chromatin condensation were noticeable.
Late apoptosis is indicated by the presence of reddish
orange colour due to the binding of AO to denatured
DNA as observed after 48 h treatment (Figure 3A).contrast inverted microscope of CEMss cells. Cells were treated at
d normal structure without prominent apoptosis induction and
s) (C) Blebbing were noticed in 48 h treatment (arrows). (D) Increasing






















Figure 3 Confocal micrograph of acridine orange and propidium iodide double-stained CEMss cells. Cells were treated at IC50 of
Boesenbergin A at time-dependent manner. (A) Untreated cells showed normal structure without prominent apoptosis and necrosis. (B) Early
apoptosis features were seen after 24 h representing intercalated acridine orange (bright green) amongst the fragmented DNA (arrows). (C) Blebbing
and nuclear margination were noticeable after 48 h treatment (arrows). (D) Late apoptosis was seen after 72 h post-treatment whereby a positive
staining of orange color represents hallmark of late apoptosis (arrows). Figure 3B Histogram representing qualitative analysis of confocal micrograph
consisting of acridine orange and propidium iodide double-stained treated and untreated CEMss cells. CEMss cell death via apoptosis increased
significantly (p < 0.05) in a time-dependent manner. However, no significant (p > 0.05) difference was observed in the cell count of necrosis. (EA: early
apoptosis; LA: late apoptosis; SN: secondary necrosis). ‘*’ indicates significant differences from the control (p < 0.05).
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population) showed that there is a statistically signifi-
cant (P < 0.05) difference in apoptosis positive cells.
On the other hand, there was no statistically signifi-
cant (P > 0.05) difference in necrotic counts at differ-
ent treatment times (Figure 3B).
Cell cycle analysis
Flow cytometric analysis of the cell cycle and DNA content
were performed to determine the ability of boesenbergin A
to induce cell cycle arrest and apoptosis. There were no sig-
nificant changes of G1 and S in dose-dependent treatment
on CEMss cells. However, the sub G1 phase, (apoptotic
cells) showed a significant increase in a time dependent
manner (Figure 4). These results suggest that boesenbergin
A is capable of inducing significant G2/M phase arrest to
CEMss cells.
Annexin V assay
The annexin V assay revealed the induction of apoptosis
in CEMss cells at an early stage after treatment with
8 μg/ml of boesenbergin A. Negative control cells showed
91.7% viability, 1.0% in early apoptosis, 3.25% in late apop-
tosis and 4.0% in secondary necrosis, whereas after 24 h
treatment with boesenbergin A, CEMss cells showed
77.05% viability, 6.05% in early apoptosis, 11.3% in lateFigure 4 Flow cytometric analysis of cell cycle distribution in CEMss
B) 24, C) 48, and D) 72 h. Data were shown as Mean ± SEM. *p<0.05 vs
maintained at 37°C and 5% CO2.apoptosis and 5.55% in secondary necrosis. As the treat-
ment time increased to 48 h and 72 h, the percentage of
both early and late apoptotic cells continued to increase
substantially (Figure 5). This result provided evidence that
treatment of CEMss cells with boesenbergin A showed
the presence of early apoptosis, late apoptosis and second-
ary necrosis in CEMss cells as the period of treatment was
increased from 24 h to 72 h.
DNA laddering
DNA fragmentation analysis, following treatment of CEMss
cells with boesenbergin A (16 μg/ml) for 24 and 48 h,
clearly showed evidence of DNA laddering in CEMss cells
after treatment for 24 and 48 h. This appearance of DNA
laddering is similar to the positive control of HL-60 cells
treated with actinomycin (Figure 6). Untreated CEMss cells
did not provide evidence of laddering. The appearance
of DNA laddering after treatment of CEMss cells with
boesenbergin A further confirms apoptosis, due to
nuclear fragmentation.
Caspase-3/7, -8 and =-9 analyses
The assays of caspases =-3/7, -8 and =-9 showed that
boesenbergin A significantly enhanced their activity in
CEMss cells compared to untreated cells over a 24 to 72 h
time period (Figure 7), thus implying that the compoundcells treated with Boesenbergin A at 8 μg/ml for A) Untreated,
. 0 h (Control). Cells were cultured in RPMI 1640 (25 ml flask) media
Figure 5 Graph of flow cytometric analysis of Annexin V in CEMss cells which were treated with Boesenbergin A 8 μg/ml for A) Untreated
B) 24 h, C) 48 h and D) 72 h E) histogram.
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and also extrinsic pathways.
Mitochondrial membrane potential analysis
The mitochondria are an integral part of the apoptotic
machinery and an event such as the loss of mitochondrial
membrane potential (MMP) is classical evidence for apop-
tosis. To study changes in the mitochondria, the MMP was
checked using fluorescence microscopy images on treated
and untreated cells stained with Rh123 (Figure 8). The
results clearly showed that the fluorescence intensity of
Rh123 reduced as the treatment time increased. The bright
green fluorescence of control cells (Figure 8A) was reduced
significantly on boesenbergin A treatment (Figure 8D).
Protein array analysis
The pro-apoptotic protein, Bax was observed to be up-
regulated, in CEMss cells which had been treated for
72 h with boesenbergin A (8 μg/ml), whereas both the
anti-apoptotic protein, Bcl-2, and BID protein were
found to be down-regulated. Both caspase-3 and =-8
increased substantially, further confirming the earlier
assay results. Cytochrome c, survivin, XIAP and P53
protein decreased upon treatment, while TRAIL-R1 and
SMAC proteins increased (Figure 9).Western blot analysis
To confirm the changes in proteins observed in protein
array analysis and the presence of mitochondria in the
apoptosis induced by boesenbergin A, we then evaluated
the protein level using western blot analysis. Exposure of
CEMss cells to boesenbergin A increased the expression
of Bax and decreased the expression of Bcl2. Further-
more, the expression of HSP70 was down-regulated in a
concentration dependent manner (Figure 10).
Discussion
The rhizome of Boesenbergia rotunda is known to be able
to treat a lot of ailments including colic, oral diseases,
urinary disorders, dysentery and inflammation [5], how-
ever few studies have been carried out on the pure active
compounds derived from this plant. Recently, it was
found that boesenbergin A possesses cytotoxic activities
against cancer cell lines including HepG2, HT-29, A549
and PC3 [15]. In this study, the MTT assay revealed that
boesenbergin A had different degrees of cytotoxicity
against MCF-7, Hela and CEMss cells (Table 1). with
the IC50 for CEMss cells being found to be lower than
for the other cells screened. Thus, in the present study,
we focused on investigating the cytotoxic activity of
boesenbergin A and its underlying mechanism of action
Figure 6 Electrophoresis separation of fragmented DNA of untreated and treated CEMss cells for 24 h and 48 h with 16 μg/ml of
Boesenbergin A. Lane 1: Untreated cells. Lane 2: 250 base pair marker. Lane 3: Positive control which is HL-60 cells treated with actinomycin.
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Figure 7 The colourimetric assay of caspase -3/7, 8, and 9 in untreated and CEMss cells treated with Boesenbergin A 8 μg/ml for 24,
48 and 72 h. Independent t-test showed a significance (p< 0.05) between control and treated cell activity of caspase-3/7, -8 and -9.
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Figure 8 Mitochondrial membrane potential analysis for CEMss cells treated with 8 μg/ml of Boesenbergin A for A). Untreated cells
showed bright green fluorescence color (arrow). B) CEMss cells after 24 h treatment showed decrease in fluorescence intensity (arrow). C) CEMss
cells after 48 h treatment showed further decrease in fluorescence intensity (arrow). D) CEMss cells after 72 h treatment showed faded
fluorescence intensity.
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from boesenbergin A is that it has no toxic effects
against primary human blood lymphocytes.
Microscopic observations showed that, following treat-
ment with boesembergin A, the numbers of viable CEMss
cells were reduced with increasing treatment time. In
addition, indications of apoptosis in treated CEMss cells
such as cytoplasmic shrinkage and membrane blebbing
were observed [19]. It was found that the number of cells
undergoing apoptosis was more greater at earlier stages of
treatment such as after 24 h and 48 h periods. However,
when treatment time increased to 72 h, the presence of
necrosis amongst treated CEMss cells was evident. This is
possible since treated CEMss cells undergoing apoptosis
may have progressed into necrosis due to the prolonged
incubation with boesenbergin A. Treated CEMss cells
showed morphological changes that included chromatin
condensation, DNA fragmentation and membrane blebbing
when observed under confocal microscopy using AO/PI
staining. Following cell cycle analysis, we were able to
further confirm the involvement of apoptosis in CEMss
cells upon treatment with boesenbergin A in a time-
dependent pattern, as well as observing that the com-
pound induced cell cycle arrest at G2/M phase. Results
from the Annexin V assay also point to the involvement
of apoptosis in boesenbergin A treated CEMss cells.
Similar findings have been reported that panduratin A
from Boesenbergia rotunda also has the capability to
arrest cells at the G2/M phase and induce apoptosis inPC3 and DU145 human prostate cancer cells [12] and
A549 human non-small cell lung cancer cells [13].
In order to elucidate the mechanism of apoptosis,
DNA laddering was performed. DNA fragmentation of
CEMss cells was clearly detected after treatment with
16 μg/ml of boesenbergin A for 6 and 12 h. The ability
to cause DNA fragmentation is one of the hallmarks of
apoptotic cell death [20-22], including nuclear condensa-
tion and fragmentation, cleavage of chromosomal DNA
into internucleosomal fragments and packaging of the
dead cells into apoptotic bodies without plasma mem-
brane breakdown. These features of apoptosis differ sig-
nificantly from those of necrosis, which is morphologically
characterized by vacuolation of the cytoplasm, breakdown
of the plasma membrane and induction of inflammation
around the dying cell, attributable to the release of cellular
contents and pro-inflammatory molecules [20].
The caspase cascade signaling system is an important
component in the process of apoptosis as it is controlled
by various molecules that either enhance apoptosis or
inhibit apoptosis. In this study, the levels of caspases
=-3/7, -8, and =-9 were found to increase when CEMss
cells were incubated with boesenbergin A. The activation
of caspase-9 provides evidence that the compound is
capable of triggering apoptosis via the mitochondrial path-
way, whereas the increase in the caspase-3 level suggests
that it can trigger DNA fragmentation [23]. The increase
in the caspase-8 level is also an indication of apoptosis
taking place since this caspase is involved in mediating
Figure 9 Protein array analysis of CEMss untreated and treated cells for 72 h with 8 μg/ml of Boesenbergin A for A) Before treatment,
B) After treatment and C) Histrogram. D) The exact protein name of each dot in the array.
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Figure 10 Effect of Boesenbergin A on the levels of apoptosis regulatory proteins at 3, 6, 9, and 12h with β- actin as a loading control.
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caspase =-3/7, -8, and =-9 induced in the CEMss cells
after treatment with boesenbergin A allows fragmenta-
tion of DNA to proceed towards cell death during apop-
tosis induction. The activation of caspase-9 has previously
been found to be the step prior to the activation of
caspase-3 in the activation cascade of the mitochondrial
intrinsic pathway leading towards apoptosis [28]. This ac-
tivation of caspase-9 is well controlled by the apoptosome,
which converts procaspase-9 to caspase-9. The formation
of the apoptosome is fully dependent upon the release of
cytochrome c from the mitochondria to the cytosol and
adhering to Apaf-1 [29]. Since the role of mitochondria in
apoptosis is inevitable, we observed a reduction in MMP
as the treatment time with boesenbergin A increased. This
increase in mitochondria membrane permeability may be
due to the up and down regulation of apoptosis proteins
involved in the cell death mechanism.
There are a large number of proteins involved in the
process of apoptosis [30,31]. In order to identify the con-
tribution of central apoptosis proteins, we performed a
protein array analysis. Several proteins in both the ex-
trinsic and intrinsic pathways were investigated in thecurrent study, including those known to induce apop-
tosis, such as Bax, caspase-3, caspase-8, SMAC and
TRAILR-1 and those known to be anti-apoptotic, such
as Bcl-2, X-linked IAP (XIAP) and surviving, where
survivin and XIAP are members of the inhibitors of
apoptosis (IAP) family of proteins previously [32] and
SMAC is a pro-apoptosis protein that interacts with IAP
to relieve their inhibitory effects [33,34].
The obtained protein array results showed a typical pro-
file of protein levels associated with mitochondrial apop-
tosis in boesenbergin A treated CEMss cells. Hence we
then selected the most important proteins involved in this
pathway (Bax and Bcl-2) and conducted an immunoblot
analysis. The expression of Bax showed an increase,
whereas the expression of Bcl-2 was decreased, further
confirming the protein array results. The decreased ex-
pression of Bcl-2 was expected since Bcl-2 prevents induc-
tion of apoptosis by blocking the release of cytochrome c
from mitochondria [35]. Moreover, proteins of the Bcl-2
family are known to regulate the promotion and inhibition
of apoptosis [36]. These Bcl-2 family proteins are highly
expressed in CEMss cancer cells and therefore inhibiting
its expression in the cancer cell will trigger cell death
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proteins also have considered as apoptosis inhibitors, as
they play a significant role in the survival of cells either
my blocking the release of cytochrome c from mito-
chondria or by blocking the formation of apoptosome
[39]. The immunoblot analysis demonstrated showed
that Hsp70 was significantly reduced upon treatment
with boesenbergin A. This correlates well to a previous
study that showed that over-expression of Hsp70 was
able to suppress apoptosis [40].
On the basis of the observations mentioned in this re-
port, it can be concluded that the treatment of CEMss
with boesenbergin A induced apoptosis with cell death-
transducing signals that regulate the MMP by down-
regulation of Bcl2 and up-regulation of Bax. Cell death
was significantly controlled by both initiator and execu-
tioner caspases and resulting in the cleavage of specific
substrates leading to the process of apoptotic changes.
This form of apoptosis was found to be closely associated
with the down regulation of Hsp70 and G2/M phase cell
cycle arrest. The positive outcomes of our research pro-
vide a strong basis for developing boesenbergin A as a
novel chemotherapeutic agent for leukemia interven-
tion, which warrants further investigations including in
animal models.
Conclusion
In this current study, the results that we gather demon-
strated that boesenbergin A induced apoptosis of CEMss
cells through Bcl2/Bax signaling pathways with the
involvement of caspases and G2/M phase cell cycle ar-
rest. The current findings also warrant further research on
boesenbergin A as a novel chemotherapeutic agent for
leukemia intervention including studies in animal models.
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